semaglutide alcohol use disorder study and Tirzepatide reduce consumption in individuals with obesity GLP-1 medications: The next big

In the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) study, the incidence of cardiovascular disease was lower when liraglutide was used in patients with type 2 diabetes [15]

Fatty Fish Omega-3 fatty acids, plentiful in fatty fish like salmon, mackerel, and sardines, are known for their cardiovascular benefits

The liraglutide group not only maintained their weight loss better (81.4% versus 48.9%) but also achieved additional weight loss compared to the control group, with 50.5% versus 21.8% reaching at least 5% weight loss, respectively

"GLP-1 Benefit Coverage for Employers." June 17, 2025

Proc Natl Acad Sci 121 , e2415550121 (2024)

At Lone Star Centers, Brenda Johnson focuses on helping patients understand how Ozempic fits into their larger health goals from cardiovascular health to sustainable weight management